Posted: 14 August 2025 Noxopharm Limited is has announced the second dose cohort of SOF-SKN™ has been successfully completed in the HERACLES trial. The safety steering committee has determined the second dose level to be safe and tolerable,…
Posted: 11 August 2025 VivaZome Therapeutics has published a major review artcile in Health Nanotechnology, titled “Customised extracellular vesicle therapeutics for neurological conditions.” The paper was authored by Dr Ella Johnston, with co-authors Johannes Weber, Xenia Sango (CEO),…
Posted: 11 August 2025 Cartherics Pty Ltd officially opened its new state-of-the-art cleanroom facility in Notting Hill, Victoria, marking a significant milestone in the company’s mission to advance off-the-shelf immune stem cell therapies for women’s health. The facility…
Posted: 6 August 2025 BioNTech has officially launched a new Clinical Trial Oncology Platform in partnership with the Peter MacCallum Cancer Centre, aimed at expanding access to investigational cancer treatments across Victoria. The initiative, backed by the Allan…
Posted: 4 August 2025 Cell Therapies Pty Ltd and Viral Vector Manufacturing Facility Pty Ltd (VVMF) formalised a strategic collaboration through a memorandum of understanding (MoU) aimed at enhancing the domestic development and manufacturing of Advanced Therapy Medicinal…
Posted: 4 August 2025 Meiban Corp Holdings has entered into a strategic alliance with Planet Innovation (PI) to deliver end-to-end Contract Development and Manufacturing Organization (CDMO) services for the MedTech sector. The collaboration was designed to streamline the…
Posted: 4 August 2025 The National Reconstruction Fund Corporation (NRFC) has committed $150 million to Brandon Capital’s Brandon BioCatalyst 6 (BB6) fund, furthering efforts to develop and commercialise Australian-made therapeutics, medical devices, and vaccines. The recenly announced funding…
Posted: 4 August 2025 Australian life sciences venture capital firm Brandon Capital confirmed the final close of its sixth fund- Brandon BioCatalyst Fund 6, exceeding $430 million AUD in commitments. This marked one of the largest life sciences venture…
Posted: 4 August 2025 Researchers from RMIT University have developed a wearable wound monitoring device with sensors that could reduce infection risks by minimising the need for frequent physical contact, healing remotely via a Bluetooth connection. Conventional wound…
Posted: 4 August 2025 Coinciding with their 20-year anniversary, Chubb has launched a new insurance package – Premier Life Science – developed to meet the evolving risk landscape facing companies in the life sciences sector. The tailored package…
Posted: 31 July 2025 What happens when engineers, clinicians and entrepreneurs reimagine healthcare together? This article summarises BioMelbourne Network’s latest BioForum, where speakers from RMIT, Kali Healthcare, Nutromics, and Proton Intelligence revealed how wearable tech and smart diagnostics…
Posted: 30 July 2025 Media release Careers Hub launches to showcase diverse medical research career pathways BioMelbourne Network has today launched the Careers Hub, a comprehensive digital platform designed to showcase diverse career pathways available across the…